Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kadant (KAI) Cash & Equivalents (2016 - 2026)

Kadant (KAI) has disclosed Cash & Equivalents for 17 consecutive years, with $119.6 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents rose 26.3% to $119.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $119.6 million through Jan 2026, up 26.3% year-over-year, with the annual reading at $119.6 million for FY2026, 26.3% up from the prior year.
  • Cash & Equivalents hit $119.6 million in Q1 2026 for Kadant, down from $124.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $124.5 million in Q3 2025 to a low of $66.7 million in Q3 2023.
  • Historically, Cash & Equivalents has averaged $88.3 million across 5 years, with a median of $86.2 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: dropped 16.25% in 2022 and later soared 40.82% in 2025.
  • Year by year, Cash & Equivalents stood at $76.4 million in 2022, then surged by 35.96% to $103.8 million in 2023, then decreased by 8.83% to $94.7 million in 2024, then surged by 31.52% to $124.5 million in 2025, then dropped by 3.97% to $119.6 million in 2026.
  • Business Quant data shows Cash & Equivalents for KAI at $119.6 million in Q1 2026, $124.5 million in Q3 2025, and $95.3 million in Q2 2025.